Grifols, S.A. (GRFS)
-NasdaqGS 26.95 
0.10(0.37%) 18 May 06:00|After Hours
:
26.95 0.00 (0.00%) 18 May 06:06
| Prev Close: | 26.85 |
|---|
| Open: | 26.99 |
|---|
| Bid: | N/A |
|---|
| Ask: | 30.00 x 500 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.529 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 26.73 - 27.18 |
|---|
| 52wk Range: | 15.24 - 31.63 |
|---|
| Volume: | 1,147,494 |
|---|
| Avg Vol (3m): | 522,938 |
|---|
| Market Cap: | 18.24B |
|---|
| P/E (ttm): | 50.90 |
|---|
| EPS (ttm): | 0.53 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 5.32 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Grifols, S.A., a specialty biopharmaceutical company, develops, manufactures, and distributes a range of plasma derivative products primarily in the European Union, Spain, the United States, and Canada.
View More